EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isoform Switching Regulates the Response to Ionizing Radiation Through SRSF1

Majd Abdulghani, Niema B Razavian, Joshua T Burdick, Enric Domingo, Vivian G Cheung, Timothy C Humphrey

International Journal of Radiation Oncology*Biology*Physics · 2024

DOI: 10.1016/j.ijrobp.2024.02.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Majd Abdulghani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rhodes Trust and; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Serine-Arginine Splicing Factors, Radiation Tolerance, Protein Isoforms, Alternative Splicing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rhodes Trust, National Institutes of Health, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study investigated how isoform switching affects the cellular response to ionizing radiation (IR), an understudied area despite its relevance to radiation therapy in cancer treatment. We aimed to identify changes in transcript isoform expression post-IR exposure and the proteins mediating these changes, with a focus on their potential to modulate radiosensitivity. METHODS AND MATERIALS: Using RNA sequencing, we analyzed the B-cell lines derived from 10 healthy individuals at 3 timepoints, applying the mixture of isoforms algorithm to quantify alternative splicing. We examined RNA binding protein motifs within the sequences of IR-responsive isoforms and validated the serine/arginine-rich splicing factor 1 (SRSF1) as a predominant mediator through RNA immunoprecipitation. We further investigated the effects of SRSF1 on radiosensitivity by RNA interference and by analyzing publicly available data on patients with cancer. RESULTS: We identified ∼1900 radiation-responsive alternatively spliced isoforms. Many isoforms were differentially expressed without changes in their overall gene expression. Over a third of these transcripts underwent exon skipping, while others used proximal last exons. These IR-responsive isoforms tended to be shorter transcripts missing vital domains for preventing apoptosis and promoting cell division but retaining those necessary for DNA repair. Our combined computational, genetic, and molecular analyses identified the proto-oncogene SRSF1 as a mediator of these radiation-induced isoform-switching events that promote apoptosis. After exposure to DNA double-strand break-inducing agents, SRSF1 expression decreased. A reduction in SRSF1 increased radiosensitivity in vitro and among patients with cancer. CONCLUSIONS: We establish a pivotal role for isoform switching in the cellular response to IR and propose SRSF1 as a promising biomarker for assessing radiation therapy effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine-Arginine Splicing FactorsRadiation ToleranceProtein IsoformsAlternative SplicingProto-Oncogene MasRadiation, IonizingHumansExons

Substanzen

Serine-Arginine Splicing FactorsSRSF1 protein, humanProtein IsoformsMAS1 protein, humanProto-Oncogene Mas

Autor:innen und Institutionen

  • Rhodes Trust and; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
  • Department of Pediatrics and Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.
  • Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
  • Department of Pediatrics and Life Sciences Institute, University of Michigan, Ann Arbor, Michigan. Electronic address: vgcheung@umich.edu.
  • Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, United Kingdom; Genome Damage and Stability Centre, University of Sussex, Brighton, East Sussex, United Kingdom. Electronic address: timot…

Förderung

  • Rhodes Trust
  • National Institutes of Health
  • Howard Hughes Medical Institute
  • Royal Embassy of Saudi Arabia Cultural Bureau in London
  • UKRI Medical Research Council
  • Cancer Research UK

Zitieren

APA

Abdulghani, M., Razavian, N. B., Burdick, J. T., Domingo, E., Cheung, V. G., & Humphrey, T. C. (2024). Isoform Switching Regulates the Response to Ionizing Radiation Through SRSF1. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.02.024

Vancouver

Abdulghani M, Razavian NB, Burdick JT, Domingo E, Cheung VG, Humphrey TC. Isoform Switching Regulates the Response to Ionizing Radiation Through SRSF1. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.02.024

BibTeX
@article{Abdulghani2024,
  author = {Abdulghani, Majd and Razavian, Niema B and Burdick, Joshua T and Domingo, Enric and Cheung, Vivian G and Humphrey, Timothy C},
  title = {Isoform Switching Regulates the Response to Ionizing Radiation Through SRSF1},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  doi = {10.1016/j.ijrobp.2024.02.024}
}
Kostenlos starten →